Bloem BR, Macklin EA, Schwarzschild MA (2025) GLP-1 agonists to slow down Parkinsons progression
Review: Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes A new review article published in the journal Acta Pharmaceutica Sinica B summarizes advancements in drug delivery systems for three main glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are recommended for selected patients with obesity or type 2 diabetes, depending on indication, comorbidities, and treatment goals
Retatrutide reverses the pro-fibrotic metabolomic profile in adipose tissue Metabolomic analysis revealed a distinct pro-fibrotic metabolic signature in the eWAT of HFD-fed mice compared to the NCD group
The Good Measures approach of combining digital technology with personalized clinical nutrition coaching is engaging, easy for members to access, and impactful by delivering meaningful health outcomes, Good Measures chief executive Donna K
Whether youre crushing workouts, competing, or just pushing your limits, our Athlete Recovery IV is your secret to faster bounce-back
Is there a link between cravings and circadian rhythm disruption